HHRI News & Press Releases
September 22, 2026 -- A transition is underway in the management of the nation's transplant data infrastructure. Publicis Sapient, a global digital business transformation company, is in the process of taking over fundamental elements of the Scientific Registry of Transplant Recipients (SRTR) contract, from the Hennepin Healthcare Research Institute (HHRI). The transition is currently in progress. The IT infrastructure transition is expected to be fully completed by December 1, 2026, with other contract element timelines yet to be determined.
SRTR is a vital national resource that supports the transplant community through comprehensive data analysis, with a core mission of improving patient outcomes and experience. It operates under a contract from the Division of Transplantation (DoT), Health Systems Bureau (HSB), Health Resources and Services Administration (HRSA), U.S. Department of Health and Human Services (HHS). The registry provides program-specific reports on transplant programs and organ procurement organizations, offering wide-ranging information to clinicians, researchers, and patients.
HHRI has been a cornerstone of medical research since 1952, supporting and overseeing research conducted at HCMC, the flagship acute care and teaching hospital of the Hennepin Healthcare System in downtown Minneapolis. As one of the largest medical research nonprofits in Minnesota, HHRI often ranks in the top ten percent nationally of institutions receiving research grants from the National Institutes of Health (NIH). The organization, through its Chronic Disease Research Group (CDRG), has operated SRTR for over 15 years with a steadfast commitment to its mission of transforming health and health care for all through ethical research and meaningful community partnerships.
The transition from HHRI to Publicis Sapient is being conducted collaboratively to ensure a seamless transfer of responsibilities and the continued integrity of SRTR's operations. Both organizations are dedicated to ensuring that the registry continues to provide reliable, data-driven insights that are essential for the transplant community and the patients they serve.
Further updates will be provided as the transition progresses.
More HHRI Research Highlights
HHRI Awarded Continuation of SRTR Contract
Minneapolis, Minn. – The Chronic Disease Research Group (CDRG) of the Hennepin Healthcare Research Institute (HHRI) has renewed its federal contract to operate the Scientific Registry of Transplant Recipients (SRTR). Among its key functions, the SRTR evaluates the status of the nation’s solid organ transplant system and provides analytic support to…
Read More
Hennepin Healthcare takes a pulse of the pandemic
by hennepinmedical — COVID-19’s rapid arrival in Minnesota in March 2020 created myriad changes across the community – and a snapshot of that impact is now available in a report from Hennepin Healthcare. A collaboration for quality improvement between Hennepin Healthcare and Hennepin Healthcare Research Institute (HHRI) emerged to design…
Read More
New website offers added decision support for kidney and liver transplant candidates searching for a transplant center
Minneapolis, Minn. – Transplant candidates face obstacles in finding a transplant program that transplants patients like them. A new online tool developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is helping to remove those barriers. The website transplantcentersearch.org allows patients to conduct searches…
Read More
Hennepin Healthcare collaborates with Mayo Clinic on convalescent plasma protocol as a therapeutic treatment for COVID-19 patients
Minneapolis, Minn. – Hennepin Healthcare Research Institute (HHRI) is collaborating with the Mayo Clinic to engage in a clinical protocol using convalescent plasma as a therapeutic treatment for COVID-19 patients. Convalescent plasma has appeared to be of benefit for the treatment of certain infectious diseases, including infections from respiratory viruses.…
Read More
Hennepin Healthcare partners with University of Minnesota on COVID-19 clinical trials of blood pressure drug losartan
Hennepin Healthcare Research Institute (HHRI) and University of Minnesota Medical School researchers have begun enrolling patients in newly launched clinical trials involving a blood pressure medication, losartan, as a potential treatment for those recently diagnosed with COVID-19. Both studies are multi-site trials, one for patients requiring hospitalization and the other…
Read More
Hennepin Healthcare launches two clinical trials to study the investigational antiviral drug remdesivir to treat hospitalized patients with COVID-19
Minneapolis, Minn. – April 9, 2020 – The Hennepin Healthcare Research Institute (HHRI) has launched two clinical trials to study the safety and efficacy of remdesivir to treat hospitalized patients diagnosed with moderate or severe COVID-19, the disease caused by the novel coronavirus SARS-CoV-2. Hennepin Healthcare is a clinical site…
Read More
Exploratory study identifies key factors associated with time pressure in primary care clinicians
Physicians often feel pressed for time during the standard primary care visit. Recent studies have shown that shorter visits are not only common but also lead to unaddressed health issues and a diminished understanding of patient concerns. Thus, it is critical to understand the relationship between time pressure, worklife factors…
Read More
New online tool helps transplant candidates find center that best matches individual patient’s criteria
A new website developed by researchers at Hennepin Healthcare Research Institute (HHRI) and the University of Minnesota (UMN) is making it easier for organ transplant candidates to choose which transplant center is right for them. The website, transplantcentersearch.org, was developed for candidates seeking kidney, liver, heart and lung transplants. Data…
Read More